Application
Western blot analysis of TM222 Antibody (Center) in mouse bladder tissue lysates (35ug/lane).TM222 (arrow) was detected using the purified Pab.Application
TM222 Antibody (Center) IHC analysis in formalin fixed and paraffin embedded bladder carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the TM222 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | TM222 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | C1orf160 |
|---|---|
| Alternative Names | TMEM222 C1orf160 Transmembrane protein 222 |
| Molecular Weight(MW) | 23230 Da |
| Tissue Specificity | This TM222 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 155-185 amino acids from the Central region of human TM222. |
| Cellular Localization | Membrane; Multi-pass membrane protein (Potential) |
| Entrez Gene | 84065 |
|---|
Application
Western blot analysis of TM222 Antibody (Center) in mouse bladder tissue lysates (35ug/lane).TM222 (arrow) was detected using the purified Pab.
Application
TM222 Antibody (Center) IHC analysis in formalin fixed and paraffin embedded bladder carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the TM222 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
